ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 15L • 2015 ACR/ARHP Annual Meeting

    Identification of Four-and-a-Half-LIM Domain 1 (FHL1) As a New Autoantibody Target in Idiopathic Inflammatory Myopathies

    Inka Albrecht1, Cecilia Wick1, Åsa Hallgren2, Anna Tjärnlund1, Kanneboyina Nagaraju3, Felipe Andrade4, Kathryn Thompson5, William Coley5, Aditi Phadke6, Lina-Marcela Diaz-Gallo1, Matteo Bottai7, Inger Nennesmo8, Karine Chemin9, Jessica Herrath10, Karin Johansson1, Anders Wikberg1, Jimmy Ytterberg1, Roman Zubarev1, Olof Danielsson11, Olga Krystufkova12, Jiri Vencovsky13, Nils Landegren2, Marie Wahren-Herlenius14, Leonid Padyukov15, Olle Kämpe2 and Ingrid E. Lundberg16, 1Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 2Experimental Endocrinology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 3The George Washington University Medical Center, Children's National Medical Center, Washington, DC, 4Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, 5Children's National Medical Center, Washington, DC, 6Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC, 7Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 8Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, 9Medicine, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 10Department of Medicine,, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 11Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University, Linköping, Sweden, 12Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 13Rheumatology, Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 14Department of Medicine, Experimental Rheumatology Unit, Solna, Sweden, 15Department of medicine, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 16Karolinska University Hospital, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare systemic autoimmune diseases collectively called myositis causing progressive muscle weakness. Interestingly, myositis-specific autoantibodies described…
  • Abstract Number: 2445 • 2015 ACR/ARHP Annual Meeting

    Development and Usability Testing of an Ipad-Based Psycho-Educational Game for Children with Juvenile Idiopathic Arthritis and Their Parents

    Jennifer N. Stinson1, Adam M. Huber2, Mark Connelly3, Nadia Luca4, Lynn R. Spiegel5, Argerie Tsimicalis6, Stephanie Luca7, Roberta Berard8, Julie Barsalou9, Sarah Campillo10, Paul Dancey11, Ciarán M. Duffy12, Brian Feldman13, Nicole Johnson4, Patrick McGrath14, Natalie J. Shiff15, Shirley M Tse16, Lori B. Tucker17 and J. Charles Victor18, 1Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 2Pediatric rheumatology, IWK Health Centre, Halifax, NS, Canada, 3Psychology, University of Kansas Medical Center, Kansas City, KS, 4Pediatrics/Alberta Children's Hospital, Department of Pediatrics/University of Calgary, Calgary, AB, Canada, 5Rheumatology/Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada, 6McGill University, Montreal, QC, Canada, 7The Hospital for Sick Children, Toronto, ON, Canada, 8Children's Hospital of Western Ontario, London, ON, Canada, 9CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada, 10Rheumatology, Montreal Children's Hospital, Montreal, QC, Canada, 11Health Science Centre, Memorial University of Newfoundland, St Johns, NF, Canada, 12Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 13Division of Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 14IWK Health Centre, Halifax, NS, Canada, 15Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, 16Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 17Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 18University of Toronto, Toronto, ON, Canada

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is a common chronic childhood illness that can negatively impact health-related quality of life (HRQL). In younger years, children manage…
  • Abstract Number: 2446 • 2015 ACR/ARHP Annual Meeting

    Synovial Fluid Proteins Differentiate Patients with Oligoarticular Juvenile Idiopathic Arthritis Who Are Destined to Extend from Those Who Will Remain Persistent in Course

    AnneMarie C. Brescia1, Megan M. Simonds2, Kathleen E. Sullivan3 and Carlos D. Rose4, 1Pediatric Rheumatology, Nemours A.I. duPont Hospital for Children, Wilmington, DE, 2Nemours Research, Nemours/AI duPont Hospital for Children, Wilmington, DE, 3Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, 4Pediatrics, Nemours A.I. duPont Hospital for Children, Division of Pediatric Rheumatology, Thomas Jefferson University, Wilmington, DE

    Background/Purpose: Children with oligoarticular juvenile idiopathic arthritis (JIA) who have an extended course (recruitment of 5 or more joints after 6 months of disease) have…
  • Abstract Number: 2447 • 2015 ACR/ARHP Annual Meeting

    The Juvenile Arthritis Disease Activity Score Remains the Disease Activity Marker of Choice for Adults with Polyarticular Juvenile Idiopathic Arthritis

    Qiong Wu1, Nicola Ambrose1,2,3, Debajit Sen1,2,3, Maria J. Leandro4, Charlotte Wing2, Nicola Daly2, Kate Webb1,2, Corinne Fisher1,2, Linda Suffield1, Francesca Josephs1, Clarissa Pilkington3, Despina Eleftheriou1,3, Muthana Al-Obaidi3, Sandrine Compeyrot-Lacassagne3, Lucy R Wedderburn1,3 and Yiannis Ioannou1,2,3, 1Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom, 2Adolescent Rheumatology Department, University College London Hospital NHS Trust, London, United Kingdom, 3Paediatric Rheumatology Department, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 4Centre for Rheumatology and Bloomsbury Rheumatology Unit, University College London, London, United Kingdom

    Background/Purpose: A considerable proportion of children with polyarticular juvenile idiopathic arthritis (polyJIA) continue to experience active disease into adulthood. There is no validated disease activity…
  • Abstract Number: 2448 • 2015 ACR/ARHP Annual Meeting

    Flare Definitions for Juvenile Idiopathic Arthritis (JIA) Based on ACR Core Set Variables and Patient Reported Outcomes: Results from the Research in Arthritis in Canadian Children-Emphasizing Outcomes Prospective Cohort

    Vinay Shivamurthy1, Deborah M. Levy2, Gilles Boire3, Karen N Watanabe Duffy4, Elizabeth Stringer5, Rosie Scuccimarri6, Rae S.M. Yeung7, Adam M. Huber8, Kiem Oen9, Natalie Shiff10, Lori B. Tucker11, Roberta Berard12, Kimberly Morishita13, Ciarán M. Duffy14 and Jaime Guzman15, 1Pediatrics/Rheumatology, British Columbia Children's Hospital, Vancouver, BC, Canada, 2Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 3Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 6Pediatrics, McGill University, Montréal, QC, Canada, 7Pediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 8Pediatric rheumatology, IWK Health Centre, Halifax, NS, Canada, 9University of Manitoba, Winnipeg, MB, Canada, 10Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, 11Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 12Children's Hospital of Western Ontario, London, ON, Canada, 13Pediatric Rheumatology, BC's Children's Hospital, Vancouver, BC, Canada, 14Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 15Rheumatology, Division of Rheumatology, BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: A valid flare definition is needed in clinical practice to identify a clinically relevant worsening which will guide us make treatment decisions. While the…
  • Abstract Number: 2449 • 2015 ACR/ARHP Annual Meeting

    Does Antinuclear Antibodies Predict Remission in JIA ?

    Mia Glerup1, Troels Herlin2 and Marinka Twilt3, 1Pediatrics, Aarhus University Hospital, Skejby, Aarhus, Denmark, 2Department of Pediatrics, Århus University Hospital Skejby, Århus, Denmark, 3Rheumatology, Alberta Children's Hospital, Calgary, AB, Canada

    Background/Purpose: In the recent years the classification of Juvenile Idiopathic Arthritis (JIA) according to the ILAR criteria has been questioned as some categories still include…
  • Abstract Number: 2450 • 2015 ACR/ARHP Annual Meeting

    Examination of the Clinical Significance of 14-3-3 Eta in Juvenile Idiopathic Arthritis

    Lance Feller1, Austin M. Dalrymple2, Paul Tuttle IV3, Reema H. Syed3, Peri Pepmueller1 and Terry Moore4, 1Rheumatology, Saint Louis University, St. Louis, MO, 2Pediatric Rheumatology, St. Louis University, St. Louis, MO, 3IM-Rheumatology, Saint Louis University, St. Louis, MO, 4Division of Rheumatology and Pediatric Rheumatology, Saint Louis University School of Medicine, St Louis, MO

    Background/Purpose: 14-3-3 proteins are chaperonins found in all eukaryotic cells. There are multiple isoforms which are thought to be involved in intracellular signaling and transcription…
  • Abstract Number: 2451 • 2015 ACR/ARHP Annual Meeting

    Scoring Medication Requirements and Side-Effects in Juvenile Idiopathic Arthritis: Perspectives of Patients, Parents and Clinicians

    Lori B. Tucker1, Natalie Shiff2, Susanne Benseler3, Roberta Berard4, Roman Jurencak5, Thomas Loughin6, Jaime Guzman7 and Andrew Henrey6, 1Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 2Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, 3Pediatrics, University of Calgary, Toronto, ON, Canada, 4Children's Hospital of Western Ontario, London, ON, Canada, 5University of Ottawa, Ottawa, ON, Canada, 6Statistics and Actuarial Science, Simon Fraser University, Burnaby, BC, Canada, 7Rheumatology, Division of Rheumatology, BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: Medication requirements (MedReq) and medication side effects (MedSE) were found to be top priorities by patients, parents and clinicians in describing the course of…
  • Abstract Number: 2452 • 2015 ACR/ARHP Annual Meeting

    Clinical and Functional Outcomes in Patients with Polyarticular Juvenile Idiopathic Arthritis Following Treatment with Adalimumab

    Daniel J. Kingsbury1, Pierre Quartier2, G Horneff3, Kirsten Minden4, Mary Toth5, Nupun A. Varothai6, Anabela Cardoso7 and Jasmina Kalabic6, 1Randall Children's Hospital at Legacy Emanuel, Portland, OR, 2Hopital Necker-Enfants Malades, Paris, France, 3Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, 4Kinderklinik der Charite, Otto-Heubner Centrum, Berlin, Germany, 5Akron Children's Hospital, Akron, OH, 6AbbVie, North Chicago, IL, 7AbbVie, Amadora, Portugal

    Background/Purpose: The Juvenile Arthritis Disease Activity Score (JADAS) is increasingly accepted for defining a treat-to-target strategy in patients (pts) with juvenile idiopathic arthritis (JIA)1 The…
  • Abstract Number: 2453 • 2015 ACR/ARHP Annual Meeting

    Evidence-Based Decision Support for Pediatric Rheumatology Reduces Diagnostic Errors, with the Potential to Reduce Capacity Shortage

    Balu Athreya1, Mary Beth Son2, Jonathan S. Hausmann3, Elizabeth Ang4, David Zurakowski5, Michael Segal6 and Robert Sundel7, 1duPont Hospital for Children/Thomas Jefferson University, Wilmington, DE, 2Division of Immunology, Children's Hospital Boston, Boston, MA, 3Rheumatology, Children's Hospital Boston, Boston, MA, 4Paediatrics, University Children's Medical Institute, NUH, Singapore, Singapore, 5Departments of Anesthesia and Surgery, Boston Children’s Hospital, Boston, MA, 6SimulConsult, Chestnut Hill, MA, 7Immunology, Childrens Hospital, Boston, MA

    Background/Purpose: This projects seeks to respond to the critical shortage of pediatric rheumatologists encapsulating the diagnostic information of the field in an advanced diagnostic decision…
  • Abstract Number: 2454 • 2015 ACR/ARHP Annual Meeting

    Target and Targetoid Reactions at Bacillus Calmettee-Guérin Inoculation Site Revealed By Dermatoscopy Correlate with Systemic Involvements in Patients with Kawasaki Disease

    Kuo Ho-Chang and Kawasaki Disease Center, Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

    Background/Purpose: For the past decades, the rash at the Bacillus Calmettee-Guérin (BCG) inoculation sites has been recognized as a useful diagnostic clue in Kawasaki disease…
  • Abstract Number: 2455 • 2015 ACR/ARHP Annual Meeting

    Utilization and Education of Nurse Practitioners in Pediatric Rheumatology

    Sandra Mintz1, Karla B. Jones2 and Andreas Reiff3, 14650 Sunset Boulevard, Mailstop 60, Children's Hospital of LA, Los Angeles, CA, 2Rheumatology, Nationwide Children's, Columbus, OH, 3Childrens Hosp LA MS60, Los Angeles, CA

    Background/Purpose: Due to the shortage of subspecialty physicians there is an increasing  need of adding mid-level practitioners to specialty practices (Solomon, Bitton, et.al., 2014).  However…
  • Abstract Number: 2456 • 2015 ACR/ARHP Annual Meeting

    Anti SRP+Ve Myositis in Childhood. Presentation and Physiotherapy Treatment of This Rare Childhood Myositis

    Susan Maillard and Clarissa Pilkington, Paediatric Rheumatology, Great Ormond Street Hospital NHS Foundation Trust for Children, London, United Kingdom

    Background/Purpose: Previously it was understood that all Myositis in childhood was Juvenile Dermatomyositis. More recently Myositis specific antibodies have been discovered and these appear to…
  • Abstract Number: 2457 • 2015 ACR/ARHP Annual Meeting

    Physical Function and Psychological Well-Being in Teens with Juvenile Idiopathic Arthritis (JIA): Characterization and Exploration of Technology-Assisted Self-Management

    Carrie Shotwell1, Paula Melson2, Jason Long3 and Tracy Ting4, 1Occupational therapy and physical terapy, Cincinnati Children's Hospital Medical Center, CINCINNATI, OH, 2Rheumatology, Children's Hosp Medical Center, Cincinnati, OH, 3Orthopaedic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Rheumatology/MLC 4010, Cincinnati Children's Hosp, Cincinnati, OH

    Background/Purpose: This study sought to assess the physical function and psychological well- being of teens with juvenile idiopathic arthritis (JIA) as well as to assess…
  • Abstract Number: 2458 • 2015 ACR/ARHP Annual Meeting

    Psychostimulant-Induced Vasculopathy: A Retrospective Study in a Pediatric Rheumatology Clinic

    Freda Singletary1, Nirupma Sharma1 and Rita Jerath2, 1Pediatrics, Georgia Regents University-Children's Hospital of Georgia, Augusta, GA, 2Dept of Pediatrics, Childrens Med Ctr Med Schl GA, Augusta, GA

    Background/Purpose:  Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood.  The first line treatment is psychostimulant medications namely, methylphenidate, amphetamines, or their derivatives. …
  • « Previous Page
  • 1
  • …
  • 1633
  • 1634
  • 1635
  • 1636
  • 1637
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology